Recombinetics Awarded National Institutes of Health Funding to Develop Genetically Engineered Swine Model of Glioblastoma, the Deadliest Type of Brain Tumor

In honor of Glioblastoma Awareness Day (#GBMDay), Recombinetics today announced it has received a grant from the National Cancer Institute (NCI), part of the National [...]

Recombinetics Awarded National Institutes of Health Funding to Develop Genetically Engineered Swine Model of Glioblastoma, the Deadliest Type of Brain Tumor2019-07-17T13:18:21-05:00

Recombinetics Launches TARGET-TB with Researchers in the Republic of Ireland and Northern Ireland to Develop Genome Editing Solutions for Bovine Tuberculosis

Research aims to reduce the public health risk and financial costs associated with this disease Recombinetics announced today the launch of TARGET-TB, a tripartite collaborative [...]

Recombinetics Launches TARGET-TB with Researchers in the Republic of Ireland and Northern Ireland to Develop Genome Editing Solutions for Bovine Tuberculosis2018-10-05T18:21:36-05:00
Go to Top